← Leaderboards
Min Jin Ha
University Of Tx Md Anderson Can Ctr
$188,790
Attributed
$377,579
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $208.8K · FY2018–19$250K$187.5K$125K$62.5K$0
'18
'19
Funding mix
By agency
NIH$377,579 · 1
By mechanism
R21$377,579 · 1
Top collaborators
- Veerabhadran Baladandayuthapani2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Steven M Kornblau$5,167,204
- Michael W Andreeff$17,991,896
- Han Liang$9,209,663
- Michael Davies$11,575,720
- Ronald Anthony Depinho$97,148,322
Others in their field
Other Emerging Leaders on “Antineoplastic Agents”
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$29,626,259
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Jeffrey H. Price · Vala Sciences, Inc.$5,562,326
Research focus
Antineoplastic AgentsArchitectureBaseBayesian ModelingBiologicalBiologyCalibrationCancer GenomicsCancer ProteomicsCancer TypeCell LineClinically RelevantClinical SensitivityCohortCommon NeoplasmCommunicationCommunitiesComputer SoftwareDatabasesDrug SensitivityEffective TherapyEpigenomicsFlexibilityAnalytical Method